UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research

Current pharmaceutical design, 2012-11, Vol.18 (32), p.5008-5014

2012

Volltextzugriff (PDF)

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem

Sleep (New York, N.Y.), 2022-03, Vol.45 (3), p.1

2022

Volltextzugriff (PDF)

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

Epilepsy & behavior, 2018-11, Vol.88, p.162-171

2018

Volltextzugriff (PDF)

Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data

Psychopharmacology, 2022-01, Vol.239 (1), p.1-13

2022

Volltextzugriff (PDF)

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Journal of clinical psychopharmacology, 2019-01, Vol.39 (1), p.46-56

2019

Volltextzugriff (PDF)

Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology

Journal of opioid management, 2017-11, Vol.13 (6), p.485-523

2017

Volltextzugriff (PDF)

Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications

BBA - General Subjects, 2003-02, Vol.1619 (3), p.283-290

2003

Volltextzugriff (PDF)

Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users

Epilepsy & behavior, 2018-01, Vol.78, p.194-201

2018

Volltextzugriff (PDF)

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

Journal of clinical psychopharmacology, 2015-08, Vol.35 (4), p.396-405

2015

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Crossover Study Evaluating the Abuse Potential of the Antiepileptic Drug Lacosamide in Healthy Recreational Drug Users

Journal of clinical psychopharmacology, 2017-12, Vol.37 (6), p.675-683

2017

Volltextzugriff (PDF)

Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 Studies

Journal of clinical psychopharmacology, 2020-11, Vol.40 (6), p.568-578

2020

Volltextzugriff (PDF)

Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial

Epilepsy & behavior, 2016-08, Vol.61, p.63-71

2016

Volltextzugriff (PDF)

Human abuse liability evaluation of CNS stimulant drugs

Neuropharmacology, 2014-12, Vol.87, p.81-90

2014

Volltextzugriff (PDF)

Down-Regulation of Hepatic Nicotine Metabolism and a CYP2A6-Like Enzyme in African Green Monkeys after Long-Term Nicotine Administration

Molecular pharmacology, 2003-01, Vol.63 (1), p.96-104

2003

Volltextzugriff (PDF)

Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users

Journal of opioid management, 2016-05, Vol.12 (3), p.165-180

2016

Volltextzugriff (PDF)

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users

Pain medicine (Malden, Mass.), 2018-08, Vol.19 (8), p.1597-1612

2018

Volltextzugriff (PDF)

Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users

Journal of opioid management, 2011-05, Vol.7 (3), p.179-192

2011

Volltextzugriff (PDF)

Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study

Journal of clinical psychopharmacology, 2016-08, Vol.36 (4), p.314-323

2016

Volltextzugriff (PDF)

Reducing subject burden: Identifying critical measures in human abuse potential studies using factor analysis

Drug and alcohol dependence, 2014-07, Vol.140, p.e121-e121

2014

Volltextzugriff (PDF)

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

Neuropsychiatric disease and treatment, 2014-01, Vol.10 (default), p.1161-1174

2014

Volltextzugriff (PDF)

Effects of low-dose opioids on cognitive dysfunction

Journal of clinical oncology, 2011-11, Vol.29 (32), p.4342-4343

2011

Volltextzugriff (PDF)

Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users

Journal of opioid management, 2012-09, Vol.8 (5), p.315-327

2012

Volltextzugriff (PDF)

Effect of co-administration of naloxone on intravenous hydromorphone abuse potential in non-treatment-seeking, opioid-dependent drug users

Drug and alcohol dependence, 2015-01, Vol.146, p.e176-e177

2015

Volltextzugriff (PDF)

Review of human abuse potential study methodology for abuse-deterrent formulations

Drug and alcohol dependence, 2014-07, Vol.140, p.e199-e199

2014

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended‐Release Tablets

Clinical pharmacology in drug development, 2019-01, Vol.8 (1), p.32-39

2019

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(55)
Dissertationen
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Psychiatry
(25)
Male
(24)
Adult
(22)
Female
(22)
Middle Aged
(21)
Double-Blind Method
(19)
Pharmacology & Pharmacy
(19)
Cross-Over Studies
(18)
Young Adult
(13)
Abuse Potential
(12)
Adolescent
(12)
Dose-Response Relationship, Drug
(10)
Neurosciences & Neurology
(10)
Clinical Neurology
(8)
Analgesics, Opioid - Adverse Effects
(5)
Biological And Medical Sciences
(5)
Clinical
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology

Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications

Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Crossover Study Evaluating the Abuse Potential of the Antiepileptic Drug Lacosamide in Healthy Recreational Drug Users

Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 Studies

Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial

Human abuse liability evaluation of CNS stimulant drugs

Down-Regulation of Hepatic Nicotine Metabolism and a CYP2A6-Like Enzyme in African Green Monkeys after Long-Term Nicotine Administration

Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users

Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users

Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study

Reducing subject burden: Identifying critical measures in human abuse potential studies using factor analysis

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

Effects of low-dose opioids on cognitive dysfunction

Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users

Effect of co-administration of naloxone on intravenous hydromorphone abuse potential in non-treatment-seeking, opioid-dependent drug users

Review of human abuse potential study methodology for abuse-deterrent formulations

Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended‐Release Tablets

Suchergebnisse filtern